Global Cell & Gene Therapy Cold Chain Logistics Market, By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits, Others), By Services Offered (Tra

Global Cell & Gene Therapy Cold Chain Logistics Market, By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits, Others), By Services Offered (Transportation, Storage, Packaging) By Mode of Transportation (Air, Ground, Water), By Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others), By Region, Competition, Forecast and Opportunities, 2017-2027

Global cell & gene therapy cold chain logistics market valued at USD1316.93 million in the year 2021, that is also anticipated to grow at a CAGR of 14.29% during the forecast period, 2023-2027 to achieve a market value of USD2880.76 million by 2027F. The market growth can be attributed to growing instances of chronic diseases like cancer, cardiovascular diseases, neurological disorders. Increasing geriatric population and their susceptibility toward the chronic diseases are also supporting this growth since the demands for the treatment has increased many folds. Rapidly growing clinical trials and FDA approvals toward authorizing cell and gene therapy is also anticipated to support the growth of the global cell & gene therapy cold chain logistics market in the next five years. Increasing approvals are further supporting the surging demands for the cell & gene therapy products and their transportation to different parts of the world, thereby positively influencing the growth of the global cell & gene therapy cold chain logistics market in the future five years. Increasing number of market players in the industry, and manufacturers of the cell & gene therapy products entering the cold chain logistics market for the storage and preserving cell & gene therapy products in cold chain along with acquiring the existing small players or entering into partnerships & agreements, are expected to facilitate the growth of the global cell & gene therapy cold chain logistics market in the forecast years through 2027.

The global cell & gene therapy cold chain logistics market is segmented by component, services offered, mode of transportation, holding temperature range, end user, regional distribution, and competition landscape. Based on component, the market is further bifurcated into cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment and storage medium, cryogenic pack-out kits, and others. Cryogenic shippers are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the grounds of increasing demands for the storage and transportation of cells, tissues, and a variety of other biological samples that require extreme cold storage, for storing and transportation thus driving the growth of the global cell & gene therapy cold chain logistics market in the future five years.

AmerisourceBergen Corporation (World Courier), United Parcel Service (Marken), Catalent, Inc., BioLife Solutions, Inc., Cryoport, Inc., Atelerix Ltd., Biostor Ltd., Thermo Fisher Scientific Inc., Life Science Group Ltd (LSG), Yourway Biopharma Services Company, Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions), Be The Match Therapeutics, are among the major market players in the global platform that lead the market growth of the global cell & gene therapy cold chain logistics market.

Years considered for this report:

Historical Years: 2017- 2020

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2023 – 2027

Objective of the Study:

  • To analyze the market size of global cell & gene therapy cold chain logistics market from 2017 to 2020.
  • To estimate and forecast the market size of global cell & gene therapy cold chain logistics market from 2021 to 2022 and growth rate until 2027.
  • To classify and forecast global cell & gene therapy cold chain logistics market based on component, services offered, mode of transportation, holding temperature range, end user, regional distribution, and competition landscape.
  • To identify dominant region or segment in the global cell & gene therapy cold chain logistics market.
  • To identify drivers and challenges for global cell & gene therapy cold chain logistics market.
  • To examine competitive developments such as expansions, new service launches, mergers & acquisitions, etc., in global cell & gene therapy cold chain logistics market.
  • To identify and analyze the profile of leading players operating in global cell & gene therapy cold chain logistics market.
  • To identify key sustainable strategies adopted by market players in global cell & gene therapy cold chain logistics market.
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the service providers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global cell & gene therapy cold chain logistics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:
  • Service providers, suppliers
  • Distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cell & gene therapy cold chain logistics
  • Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as service providers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global cell & gene therapy cold chain logistics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
  • Cell & Gene Therapy Cold Chain Logistics Market, By Component:
  • Cryogenic Shippers
  • Cryogenic Storage Freezers
  • Ultra-Low Freezers
  • Cold Chain Management Systems
  • Shipment and Storage Medium
  • Cryogenic Packout Kits
  • Others
  • Cell & Gene Therapy Cold Chain Logistics Market, By Services Offered:
  • Transportation
  • Storage
  • Packaging
  • Cell & Gene Therapy Cold Chain Logistics Market by Mode of Transportation:
  • Air
  • Ground
  • Water
  • Cell & Gene Therapy Cold Chain Logistics Market, By Holding Temperature Range:
  • Cryogenic
  • Refrigerated
  • Ambient
  • Others
  • Cell & Gene Therapy Cold Chain Logistics Market, By End User:
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
  • Cell & Gene Therapy Cold Chain Logistics Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Australia
  • India
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • Israel
  • South Africa
  • Saudi Arabia
  • UAE
Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Cell & Gene Therapy Cold Chain Logistics market.

Company Information
  • Detailed analysis and profiling of additional market players (up to five).
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights


1. Service Overview
2. Research Methodology
3. Impact of COVID-19 on Global Cell & Gene Therapy Cold Chain Logistics Market
4. Executive Summary
5. Voice of Customer
5.1. Brand Awareness (Aided/Unaided)
5.2. Product Awareness
5.3. Customer Satisfaction Analysis
5.4. Pricing Analysis
5.5. Unmet Needs/Challenges
6. Global Cell & Gene Therapy Market Overview
7. Global Cell & Gene Therapy Cold Chain Logistics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits, Others {Shipment Containers, Reusable Boxes, etc.})
7.2.2. By Services Offered (Transportation, Storage, Packaging)
7.2.3. By Mode of Transportation (Air, Ground, Water)
7.2.4. By Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others {Deep Freezers, Dry Ice, etc.})
7.2.5. By End User (Pharmaceutical & BioHolding Temperature Range Companies, Academic & Research Institutes, Others)
7.2.6. By Company
7.2.7. By Region
7.3. Product Market Map
8. North America Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Services Offered
8.2.3. By Mode of Transportation
8.2.4. By Holding Temperature Range
8.2.5. By End User
8.2.6. By Country
8.3. North America: Country Analysis
8.3.1. United States Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Services Offered
8.3.1.2.3. By Mode of Transportation
8.3.1.2.4. By Holding Temperature Range
8.3.1.2.5. By End User
8.3.2. Canada Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Services Offered
8.3.2.2.3. By Mode of Transportation
8.3.2.2.4. By Holding Temperature Range
8.3.2.2.5. By End User
8.3.3. Mexico Cell & Gene Therapy Cold Chain Logistics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Services Offered
8.3.3.2.3. By Mode of Transportation
8.3.3.2.4. By Holding Temperature Range
8.3.3.2.5. By End User
9. Europe Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Services Offered
9.2.3. By Mode of Transportation
9.2.4. By Holding Temperature Range
9.2.5. By End User
9.2.6. By Country
9.3. Europe: Country Analysis
9.3.1. Germany Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Services Offered
9.3.1.2.3. By Mode of Transportation
9.3.1.2.4. By Holding Temperature Range
9.3.1.2.5. By End User
9.3.2. France Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Services Offered
9.3.2.2.3. By Mode of Transportation
9.3.2.2.4. By Holding Temperature Range
9.3.2.2.5. By End User
9.3.3. United Kingdom Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Services Offered
9.3.3.2.3. By Mode of Transportation
9.3.3.2.4. By Holding Temperature Range
9.3.3.2.5. By End User
9.3.4. Spain Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Component
9.3.4.2.2. By Services Offered
9.3.4.2.3. By Mode of Transportation
9.3.4.2.4. By Holding Temperature Range
9.3.4.2.5. By End User
9.3.5. Italy Cell & Gene Therapy Cold Chain Logistics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Component
9.3.5.2.2. By Services Offered
9.3.5.2.3. By Mode of Transportation
9.3.5.2.4. By Holding Temperature Range
9.3.5.2.5. By End User
10. Asia-Pacific Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Services Offered
10.2.3. By Mode of Transportation
10.2.4. By Holding Temperature Range
10.2.5. By End User
10.2.6. By Country
10.3. Asia-Pacific: Country Analysis
10.3.1. China Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Services Offered
10.3.1.2.3. By Mode of Transportation
10.3.1.2.4. By Holding Temperature Range
10.3.1.2.5. By End User
10.3.2. Japan Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Services Offered
10.3.2.2.3. By Mode of Transportation
10.3.2.2.4. By Holding Temperature Range
10.3.2.2.5. By End User
10.3.3. South Korea Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Services Offered
10.3.3.2.3. By Mode of Transportation
10.3.3.2.4. By Holding Temperature Range
10.3.3.2.5. By End User
10.3.4. Australia Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Component
10.3.4.2.2. By Services Offered
10.3.4.2.3. By Mode of Transportation
10.3.4.2.4. By Holding Temperature Range
10.3.4.2.5. By End User
10.3.5. India Cell & Gene Therapy Cold Chain Logistics Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Component
10.3.5.2.2. By Services Offered
10.3.5.2.3. By Mode of Transportation
10.3.5.2.4. By Holding Temperature Range
10.3.5.2.5. By End User
11. South America Cell & Gene Therapy Cold Chain Logistics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Component
11.2.2. By Services Offered
11.2.3. By Mode of Transportation
11.2.4. By Holding Temperature Range
11.2.5. By End User
11.2.6. By Country
11.3. South America: Country Analysis
11.3.1. Brazil Cell & Gene Therapy Cold Chain Logistics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Component
11.3.1.2.2. By Services Offered
11.3.1.2.3. By Mode of Transportation
11.3.1.2.4. By Holding Temperature Range
11.3.1.2.5. By End User
11.3.2. Argentina Cell & Gene Therapy Cold Chain Logistics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Component
11.3.2.2.2. By Services Offered
11.3.2.2.3. By Mode of Transportation
11.3.2.2.4. By Holding Temperature Range
11.3.2.2.5. By End User
11.3.3. Colombia Cell & Gene Therapy Cold Chain Logistics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Component
11.3.3.2.2. By Services Offered
11.3.3.2.3. By Mode of Transportation
11.3.3.2.4. By Holding Temperature Range
11.3.3.2.5. By End User
12. Middle East and Africa Cell & Gene Therapy Cold Chain Logistics Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Component
12.2.2. By Services Offered
12.2.3. By Mode of Transportation
12.2.4. By Holding Temperature Range
12.2.5. By End User
12.2.6. By Country
12.3. MEA: Country Analysis
12.3.1. Israel Cell & Gene Therapy Cold Chain Logistics Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Component
12.3.1.2.2. By Services Offered
12.3.1.2.3. By Mode of Transportation
12.3.1.2.4. By Holding Temperature Range
12.3.1.2.5. By End User
12.3.2. UAE Cell & Gene Therapy Cold Chain Logistics Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Component
12.3.2.2.2. By Services Offered
12.3.2.2.3. By Mode of Transportation
12.3.2.2.4. By Holding Temperature Range
12.3.2.2.5. By End User
12.3.3. South Africa Cell & Gene Therapy Cold Chain Logistics Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Component
12.3.3.2.2. By Services Offered
12.3.3.2.3. By Mode of Transportation
12.3.3.2.4. By Holding Temperature Range
12.3.3.2.5. By End User
12.3.4. Saudi Arabia Cell & Gene Therapy Cold Chain Logistics Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Component
12.3.4.2.2. By Services Offered
12.3.4.2.3. By Mode of Transportation
12.3.4.2.4. By Holding Temperature Range
12.3.4.2.5. By End User
12.3.5. UAE Cell & Gene Therapy Cold Chain Logistics Market Outlook
12.3.5.1. Market Size & Forecast
12.3.5.1.1. By Value
12.3.5.2. Market Share & Forecast
12.3.5.2.1. By Component
12.3.5.2.2. By Services Offered
12.3.5.2.3. By Mode of Transportation
12.3.5.2.4. By Holding Temperature Range
12.3.5.2.5. By End User
13. Market Dynamics
13.1. Drivers
13.2. Challenges
14. Patent Analysis
15. Market Trends & Developments
16. Competitive Landscape
16.1. AmerisourceBergen Corporation (World Courier)
16.2. United Parcel Service (Marken)
16.3. Catalent, Inc.
16.4. BioLife Solutions, Inc.
16.5. Cryoport, Inc.
16.6. Atelerix Ltd.
16.7. Biostor Ltd.
16.8. Thermo Fisher Scientific Inc.
16.9. Life Science Group Ltd (LSG)
16.10. Yourway Biopharma Services Company
16.11. Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
16.12. Be The Match Therapeutics
17. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings